IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages.

We reported previously that IL-2 induces tumoricidal activity in IFN-gamma-treated murine macrophages. The present study was performed to investigate the regulation of IL-2-dependent tumoricidal activity in murine macrophage cell lines. The v-raf/v-myc-immortalized murine macrophage cell lines ANA-1, GG2EE, and HEN-CV did not express constitutive levels of cytotoxic activity against P815 mastocytoma cells. Moreover, these macrophage cell lines did not become tumoricidal after exposure to IL-4, IFN-gamma, IL-2 or LPS. However, these macrophages developed cytotoxic capabilities after incubation with either IFN-gamma plus IL-2 or IFN-gamma plus LPS. IL-4 inhibited IFN-gamma plus IL-2- but not IFN-gamma plus LPS-induced tumoricidal activity. This effect of IL-4 was not restricted to v-raf/v-myc-immortalized macrophage cell lines because similar results were obtained by using a macrophage cell line that was established from a spontaneous histiocytic sarcoma. The suppressive activity of IL-4 on the ANA-1 macrophage cell line was dose-dependent (approximately 12-200 U/ml) and was neutralized by the addition of anti-IL-4 mAb. IL-4 decreased the IFN-gamma-induced expression of mRNA for the p55 (alpha) subunit of the IL-2R in ANA-1 macrophages. Therefore, at least one mechanism by which IL-4 may have inhibited IFN-gamma plus IL-2-induced tumoricidal activity was by reducing macrophage IL-2R alpha mRNA expression. We have previously reported that picolinic acid, a tryptophan metabolite, is a costimulator of macrophage tumoricidal activity. We now report that IL-4 also inhibited IFN-gamma plus picolinic acid-induced cytotoxicity in ANA-1 macrophages. We propose that IL-2 and picolinic acid may have a common mechanism of action that is susceptible to IL-4 suppression.

• Publication year

  1991

• Venue

  Journal of Immunology

• Publication date

  1991-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.147.11.3809PMID 1940368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional diversity of T lymphocytes due to secretion of different cytokine patterns

  1991cited by this paper
• IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.

  1990cited by this paper
• Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes.

  1990cited by this paper
• Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFN-gamma-primed macrophages.

  1990cited by this paper
• Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages.

  1990cited by this paper
• IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells.

  1990cited by this paper
• Lymphokine-regulated differential expression of mRNA for p75kDa-IL-2R and p55kDa-IL-2R in a cloned B lymphoma line (BLC1-CL-3 cells).

  1990cited by this paper
• Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes.

  1990cited by this paper
• IL-5 up-regulates but IL-4 down-regulates IL-2R expression on a cloned B lymphoma line.

  1990cited by this paper
• Differential regulation of IL-1 production in human monocytes by IFN-gamma and IL-4.

  1990cited by this paper
• Characterization of IL-2 receptor expression and function on murine macrophages.

  1990cited by this paper
• IL-2. A cofactor for induction of activated macrophage resistance to infection.

  1990cited by this paper
• Promotion of human T lymphocyte proliferation by IL-4.

  1989cited by this paper
• Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains

  1989cited by this paper
• IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma.

  1989cited by this paper
• Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver.

  1989cited by this paper
• Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells

  1988cited by this paper
• IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.

  1988cited by this paper
• Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2

  1988cited by this paper
• Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.

  1988cited by this paper
• Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.

  1988cited by this paper
• Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.

  1988cited by this paper
• Inhibitory influence of IL-4 on human B cell responsiveness.

  1988cited by this paper
• Selective inhibition of 28S ribosomal RNA in macrophages activated by interferon-gamma or -beta.

  1987cited by this paper
• B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.

  1987cited by this paper
• A murine macrophage cell line, immortalized by v‐raf and v‐myc oncogenes, exhibits normal macrophage functions

  1987cited by this paper
• Interleukin 4 is a growth factor for activated thymocytes: possible role in T-cell ontogeny.

  1987cited by this paper
• Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.

  1987cited by this paper
• Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells.

  1987cited by this paper
• Interferon-alpha, -beta, and -gamma augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts.

  1987cited by this paper
• Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

  1986cited by this paper
• Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

  1986cited by this paper
• T-cell and mast cell lines respond to B-cell stimulatory factor 1.

  1986cited by this paper
• Molecular bases for macrophage activation.

  1986cited by this paper
• Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.

  1985cited by this paper
• Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA.

  1985cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2

  1982cited by this paper
• Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 11 indium-oxine.

  1981cited by this paper
• Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay.

  1980cited by this paper

• Th 1 type lymphocyte reactivity to metals in patients with total hip arthroplasty

  2015cites this paper
• Dissociation of Endotoxin Tolerance and Differentiation of Alternatively Activated Macrophages

  2013cites this paper
• This information is current as Macrophages Differentiation of Alternatively Activated Dissociation of Endotoxin Tolerance and

  2013cites this paper
• Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages.

  2010cites this paper
• Kynurenine Pathway Metabolites in Humans: Disease and Healthy States

  2009cites this paper
• Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty

  2008cites this paper
• Macrophage inflammatory protein (MIP)1α and MIP1β differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy

  2006cites this paper
• Murine Thi and Th 2 cell clones differentially regulate macrophage nitric oxide production

  2005cites this paper
• Soluble Factor from Murine Bladder Tumor-2 Cell Elevates Nitric Oxide Production in Macrophages and Enhances the Taxol-Mediated Macrophage Cytotoxicity on Tumor Cells

  2003cites this paper
• Zytokin-vermittelte Regulation der Interferon-gamma-induzierten IDO-Aktivität als antiparasitärer Effektormechanismus

  2002cites this paper
• Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL‐12

  2002cites this paper
• Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.

  2001cites this paper
• New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids.

  2001cites this paper
• Macrophage Control of Mycobacterial Growth Induced by Picolinic Acid Is Dependent on Host Cell Apoptosis1

  2000cites this paper
• Dependent on Host Cell Apoptosis Growth Induced by Picolinic Acid Is Macrophage Control of Mycobacterial

  1999cites this paper
• Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions.

  1996cites this paper
• Interleukin‐4 rapidly down‐modulates the macrophage colony‐stimulating factor receptor in murine macrophages

  1996cites this paper
• Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages.

  1996cites this paper
• Interferon-gamma and interleukin-2 stimulate production of a soluble factor by L1210 and P815 tumor targets to promote macrophage activation.

  1996cites this paper
• Tumor-derived recognition factor (TDRF) induces production of TNF-alpha by murine macrophages, but requires synergy with IFN-gamma alone or in combination with IL-2 to induce nitric oxide synthase.

  1996cites this paper
• Tumor-derived recognition factor (TDRF) induces production of TNF-α by murine macrophages, but requires synergy with IFN-γ alone or in combination with IL-2 to induce nitric oxide synthase

  1996cites this paper
• IL-4 inhibits IL-2-induced tumoricidal activity and secretory functions of human monocytes. Modulation of IL-2 binding and IL-2 receptor beta gamma chain expression.

  1995cites this paper
• Tumor-derived factor synergizes with IFN-gamma and LPS, IL-2 or TNF-alpha to promote macrophage synthesis of TNF-alpha and TNF receptors for autocrine induction of nitric oxide synthase and enhanced nitric oxide-mediated tumor cytotoxicity.

  1995cites this paper
• Interleukin‐2 and human monocyte activation

  1995cites this paper
• Murine Th1 and Th2 cell clones differentially regulate macrophage nitric oxide production

  1995cites this paper
• A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

  1995cites this paper
• Tumor-Derived Factor Synergizes with IFN-γ and LPS, IL-2 or TNF-α to Promote Macrophage Synthesis of TNF-α and TNF Receptors for Autocrine Induction of Nitric Oxide Synthase and Enhanced Nitric Oxide-Mediated Tumor Cytotoxicity

  1995cites this paper
• It-4 Inhibits IL-2-Induced Tumoricidal Activity and Secretory Functions of Human Monocytes

  1995cites this paper
• Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.

  1994cites this paper
• Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid.

  1994cites this paper
• Regulation of macrophage gene expression by T-cell-derived lymphokines.

  1994cites this paper
• The role of interleukin-2 in the treatment of cancer patients

  1993influential citation
• Modulation of Macrophage Function by Transforming Growth Factor β, Interleukin‐4, and Interleukin‐10 a

  1993cites this paper
• Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.

  1993cites this paper
• Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages.

  1993cites this paper
• Interleukin-2 and other cytokines

  1993cites this paper
• Vimentin expression is differentially regulated by IL-2 and IL-4 in murine T cells.

  1993cites this paper
• Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.

  1992cites this paper
• Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.

  1992cites this paper